Association of COVID-19 with New-Onset Alzheimer’s Disease

COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: A clarion call for maintaining mitigation and ramping-up research

(2022) Lindsey Wang et al.   BLOOD REVIEWS

Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period

(2022) Lindsey Wang et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

COVID‐19 breakthrough infections and hospitalizations among vaccinated patients with dementia in the United States between December 2020 and August 2021

(2022) Lindsey Wang et al.   Alzheimers & Dementia

Incidence Rates and Clinical Outcomes of SARS-CoV-2 Infection With the Omicron and Delta Variants in Children Younger Than 5 Years in the US

(2022) Lindsey Wang et al.   JAMA Pediatrics

Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Between December 2020 and November 2021

(2022) William Wang et al.   JAMA Oncology

COVID‐19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US

(2021) QuanQiu Wang et al.   Alzheimers & Dementia

How COVID-19 Affects the Brain

(2021) Maura Boldrini et al.   JAMA Psychiatry

Increased risk for COVID ‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021

(2021) Lindsey Wang et al.   World Psychiatry

Risks of SARS-CoV-2 Breakthrough Infection and Hospitalization in Fully Vaccinated Patients With Multiple Myeloma

(2021) Lindsey Wang et al.   JAMA Network Open

Dementia prevention, intervention, and care: 2020 report of the Lancet Commission

(2020) Gill Livingston et al.   LANCET

Friend, Foe or Both? Immune Activity in Alzheimer’s Disease

(2019) Georgia R. Frost et al.   Frontiers in Aging Neuroscience